B-12

Relive Health Clinic's Grand Opening in Metro Atlanta on February 22nd Features Exclusive Promotions on Anti-Aging and Wellness Solutions

Retrieved on: 
Thursday, February 15, 2024

ATLANTA, Feb. 15, 2024 /PRNewswire/ -- Today, Empire Portfolio Group ("Empire") announced the February 22nd grand opening celebration of their first Relive Health™ ("Relive") Clinic in metro Atlanta located at 5001 Peachtree Boulevard, Suite 605 in Chamblee.

Key Points: 
  • ATLANTA, Feb. 15, 2024 /PRNewswire/ -- Today, Empire Portfolio Group ("Empire") announced the February 22nd grand opening celebration of their first Relive Health™ ("Relive") Clinic in metro Atlanta located at 5001 Peachtree Boulevard, Suite 605 in Chamblee.
  • As the first of multiple locations in metro Atlanta, residents can enjoy limited-time, grand opening specials of 40% off individual services and discounts on packaged services.
  • Grand Opening promotional offers include:
    40% off All Single Services – excludes hormone therapy, medical weight loss, bloodwork and packages.
  • To RSVP and learn more about the grand opening specials, visit chamblee.relivehealth.com/GrandOpening or follow Relive Chamblee on Facebook, Instagram, and TikTok.

Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn

Retrieved on: 
Tuesday, November 28, 2023

“We are thrilled to announce the commercial availability of our first-in-class medication, VOQUEZNA, now available for the millions of people in the U.S. suffering from Erosive GERD,” said Martin Gilligan, Chief Commercial Officer at Phathom Pharmaceuticals.

Key Points: 
  • “We are thrilled to announce the commercial availability of our first-in-class medication, VOQUEZNA, now available for the millions of people in the U.S. suffering from Erosive GERD,” said Martin Gilligan, Chief Commercial Officer at Phathom Pharmaceuticals.
  • “Erosive GERD is a highly prevalent condition affecting over 20 million people in the U.S.,3,4 many of whom experience troubling symptoms, including painful heartburn.
  • Phathom is offering programs for eligible patients who face coverage or affordability issues, including co-pay assistance for patients with commercial insurance.
  • for up to 6 months to maintain healing of Erosive Acid Reflux and for relief of heartburn related to Erosive Acid Reflux.

Northwest Medical Arts Becomes Gathering Place for South Sound

Retrieved on: 
Thursday, October 12, 2023

UNIVERSITY PLACE, Wash., Oct. 12, 2023 /PRNewswire/ -- Northwest Medical Arts (NWMA), Tacoma's premier comprehensive skin health & rejuvenation center, has built its reputation on giving back and creating a space where all are welcome. They are hosting a free Halloween-themed event for all ages on Sunday, October 22 from 12pm-4pm in their parking lot at 5350 Orchard Street West in University Place, Washington.

Key Points: 
  • UNIVERSITY PLACE, Wash., Oct. 12, 2023 /PRNewswire/ -- Northwest Medical Arts (NWMA) , Tacoma's premier comprehensive skin health & rejuvenation center, has built its reputation on giving back and creating a space where all are welcome.
  • Since launch, Northwest Medical Arts has hosted several community events, received dozens of 5-star reviews and donated thousands to local families and nonprofits.
  • Northwest Medical Arts also offers their beautiful location featuring modern furnishings and warm ambiance for receptions and gatherings of home-based businesses, PTAs, moms meet ups and more.
  • Ask about hosting your next event at Northwest Medical Arts or plan a special private party with group discounts on products and services.

Spoke Sciences Acquires “SNAC” Drug Delivery Platform that Improves Bioavailability of Nutritional Supplements and Drugs

Retrieved on: 
Tuesday, July 25, 2023

Spoke has acquired from Seattle-based Receptor Life Sciences a patent portfolio covering the use of SNAC with certain non-water-soluble, e.g., “lipophilic” active ingredients.

Key Points: 
  • Spoke has acquired from Seattle-based Receptor Life Sciences a patent portfolio covering the use of SNAC with certain non-water-soluble, e.g., “lipophilic” active ingredients.
  • Because many pharmaceutical and naturally occurring compounds used in drugs, supplements and functional foods are BCS Class II, SNAC has tremendous potential.
  • Spoke Sciences is an ingredient technology company developing innovative approaches to provide better, safer, and more reliable functional ingredients to foods, beverages, and cosmetics.
  • For more information about Spoke Sciences, its patented technologies and exciting new consumer products, visit: www.spokesciences.com .

Fount Announces $12M Series A Fundraise to Redefine the Future of Human Health and Performance

Retrieved on: 
Wednesday, March 15, 2023

Fount , the pioneer in experiment-driven health and performance optimization, today announced a $12M Series A fundraise to advance its mission to make tailored health and performance optimization broadly available.

Key Points: 
  • Fount , the pioneer in experiment-driven health and performance optimization, today announced a $12M Series A fundraise to advance its mission to make tailored health and performance optimization broadly available.
  • View the full release here: https://www.businesswire.com/news/home/20230315005126/en/
    Fount: The future of health and performance is personal.
  • (Photo: Business Wire)
    Fount began its work with professional athletes and Navy SEALs and now offers the most comprehensive and customized health and performance optimization programs in the world through its flagship offering, Fount Pro.
  • "Fount sits on top of all of these point solutions delivering a personalized, experiment-driven approach to implementing the health and performance interventions that work for you.

The Worldwide Specialty Yeast Industry is Expected to Reach $4.8 Billion by 2028 at a 6.9% CAGR - ResearchAndMarkets.com

Retrieved on: 
Monday, November 21, 2022

The Global Specialty Yeast Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.9% CAGR during the forecast period.

Key Points: 
  • The Global Specialty Yeast Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.9% CAGR during the forecast period.
  • In general, the production of specialty yeast involves three steps: fermentation (yeast growth), disruption (cell breaking), and separation (to keep the soluble part).
  • The enzymes disassemble the yeast shell and break down the proteins, producing the specialized yeast products in the process.
  • Since they have the ability to enhance flavor, specialty yeast products including yeast extracts, yeast autolysates, and other yeast derivatives are utilized in food and beverage items.

Frozen Fish and Seafood Market Report 2022: Convenience for Busy and Higher-Income Earning Groups is Leading the Retail Demand for Frozen Meat - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 8, 2022

The "Frozen Fish and Seafood Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Frozen Fish and Seafood Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The frozen fish and seafood market is expected to grow at a compound annual growth rate of 6.28% over the forecast period to reach a market size of US$96.771 billion in 2027 from US$63.181 billion in 2020.
  • With the transition towards hygienic and safe food preferences, customers are inclined towards safe quality and certified frozen food.
  • As per the U.S Department of Agriculture (USDA), fish and seafood meat is preferred over chicken and red meat (mutton/beef/pork/lamb) for relatively high levels of protein, omega-3, fatty acids, and vitamins D and B-12.

Nick Stenson Beauty to Launch New Line at Ulta Beauty in November

Retrieved on: 
Wednesday, November 2, 2022

(Photo: Nick Stenson Beauty)

Key Points: 
  • (Photo: Nick Stenson Beauty)
    The line was created by award-winning global hair stylist and beauty industry leader Nick Stenson, whos passion for beauty is rooted throughout his extensive career.
  • WHAT NICK STENSON BEAUTY IS MADE OF: ALOE VERA, CREATINE + MORE
    All products in the Nick Stenson Beauty hair care collection contain Aloe Vera Gel as the key ingredient.
  • For more tips, how-to demos and ingredient information follow Nick Stenson (@nickstenson) and Nick Stenson Beauty (@nickstensonbeauty), and be fully immersed in the Consciously Curated, Naturally Luxe Nick Stenson Beauty experience.
  • ABOUT NICK STENSON BEAUTY: Nick Stenson Beauty (@nickstensonbeauty) is where nature meets luxury.

The DRIPBaR is Coming to Clarksville, TN on Oct 16, 2022

Retrieved on: 
Thursday, October 13, 2022

CLARKSVILLE, Tenn., Oct. 12, 2022 /PRNewswire-PRWeb/ -- The DRIPBaR is excited to announce the opening of its newest location in Clarksville, TN on October 16, 2022. The franchise has approximately 500+ additional locations in the pipeline.

Key Points: 
  • The DRIPBaR is excited to announce the opening of their newest location in Clarksville, TN on October 16, 2022.
  • CLARKSVILLE, Tenn., Oct. 12, 2022 /PRNewswire-PRWeb/ -- The DRIPBaR is excited to announce the opening of its newest location in Clarksville, TN on October 16, 2022.
  • Longtime locals Joel and April Gochberg, own and operate The DRIPBaR Clarksville.
  • They are excited to bring new alternative therapies to the community and are passionate about the idea behind wellness-boosting IV infusions.

Global Pernicious Anemia Market Report 2022-2028: Increasing Prevalence of Autoimmune Conditions Driving Sector Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, September 26, 2022

The "Global Pernicious Anemia Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Pernicious Anemia Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global pernicious anemia diagnosis and treatment market is anticipated to grow at a significant CAGR of 7.1% during the forecast period.
  • The increasing prevalence of autoimmune conditions or intestinal diseases is the major motivating factor for the growth of the global pernicious anemia market.
  • The competition in the global pernicious anemia diagnosis and treatment market is moderate as the companies present in the market are not so active.